-
[1]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 744-751. doi: 10.1007/s12250-020-00268-5
-
[2]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
-
[3]
Xiaoyong Zhang, Suwen Lu, Hui Li, Yi Wang, Zhen Lu, Zhihong Liu, Qingtao Lai, Yali Ji, Xuan Huang, Yongyin Li, Jian Sun, Yingsong Wu, Xiaoning Xu, Jinlin Hou, 2020: Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study, Virologica Sinica, 35, 820-829. doi: 10.1007/s12250-020-00329-9
-
[4]
Shichuan Wang, Mirko Trilling, Kathrin Sutter, Ulf Dittmer, Mengji Lu, Xin Zheng, Dongliang Yang, Jia Liu, 2020: A Crowned Killer's Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2, Virologica Sinica, 35, 673-684. doi: 10.1007/s12250-020-00298-z
-
[5]
Suyan Tian, Xuetong Zhu, Xuejuan Sun, Jinmei Wang, Qi Zhou, Chi Wang, Li Chen, Shanji Li, Jiancheng Xu, 2020: A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings, Virologica Sinica, 35, 811-819. doi: 10.1007/s12250-020-00317-z
-
[6]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
-
[7]
Ruhan A, Huijuan Wang, Wenling Wang, Wenjie Tan, 2020: Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19, Virologica Sinica, 35, 699-712. doi: 10.1007/s12250-020-00331-1
-
[8]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8
-
[9]
Ke Hu, Mengmei Wang, Yang Zhao, Yunting Zhang, Tao Wang, Zhishui Zheng, Xiaochen Li, Shaolin Zeng, Dong Zhao, Honglin Li, Ke Xu, Ke Lan, 2020: A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial, Virologica Sinica, 35, 725-733. doi: 10.1007/s12250-020-00258-7
-
[10]
Jun Ma, Yiyun Chen, Wei Wu, Zhongzhou Chen, 2021: Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2, Virologica Sinica, 36, 1104-1112. doi: 10.1007/s12250-021-00431-6
-
[11]
Zihao Wang, Zhentao Liang, Rongguo Wei, Hongwei Wang, Fang Cheng, Yang Liu, Songdong Meng, 2022: Quantitative determination of the electron beam radiation dose for SARS-CoV-2 inactivation to decontaminate frozen food packaging, Virologica Sinica, 37, 823-830. doi: 10.1016/j.virs.2022.10.007
-
[12]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
-
[13]
Haiyan Shen, Yanxing Cai, Huan Zhang, Jie Wu, Lin Ye, Penghui Yang, Xiaojun Lin, Shibo Jiang, Ming Liao, 2021: Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19, Virologica Sinica, 36, 1080-1082. doi: 10.1007/s12250-021-00371-1
-
[14]
Yang Han, Qingyu Yang, Ying Liu, Ting Shu, Li Yue, Ting Xiao, Qin Zeng, Ying Wu, Xi Zhou, Dingyu Zhang, 2020: Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening, Virologica Sinica, 35, 830-832. doi: 10.1007/s12250-020-00254-x
-
[15]
Weijie Wang, Jinxuan Yang, Pinfang Kang, Jinsong Bai, Xiaoli Feng, Liuqi Huang, Yiming Zhang, Yuechun Wu, Bi Tang, Hongju Wang, JianJie Jiang, Minghua Li, Bing Zhao, Xinglou Yang, 2023: Direct infection of SARS-CoV-2 in human iPSC-derived 3D cardiac organoids recapitulates COVID-19 myocarditis, Virologica Sinica, 38, 971-974. doi: 10.1016/j.virs.2023.09.005
-
[16]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
-
[17]
Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun, Haojie Zheng, Wei Wang, Erhei Dai, Yongzhe Li, 2023: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases, Virologica Sinica, 38, 723-734. doi: 10.1016/j.virs.2023.07.005
-
[18]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
-
[19]
Yanjun Zhang, Haiyan Mao, Ju Li, Jianhua Li, Chen Huang, Jiaxuan Li, Minglei Chu, Fengbo Xue, Linhui Wang, Zhongbiao Fang, Zhen Wang, Jinan Wu, Keda Chen, 2023: Delta (B.1.617.2) inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques, Virologica Sinica, 38, 627-630. doi: 10.1016/j.virs.2023.05.009
-
[20]
Fan Shen, Chun Liang, Cui-Xian Yang, Ying Lu, An-Qi Li, Ying Duan, Mi Zhang, Ren-Rong Tian, Xing-Qi Dong, Yong-Tang Zheng, Wei Pang, 2024: SARS-CoV-2 breakthrough infections following inactivated vaccine vaccination induce few neutralizing antibodies against the currently emerging Omicron XBB variants, Virologica Sinica, 39, 173-176. doi: 10.1016/j.virs.2023.11.007